Wikidata

(Q61957401)

English

A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Phase II Study of Flumatinib Versus Imatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) (English)
0 references
start time
August 2011
0 references
end time
June 2012
0 references
number of participants
150
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61957401&oldid=2149379367"